|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/46 | |
| A61P 3/00 |
| (11) | Number of the document | 2793933 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12860231.5 |
| Date of filing the European patent application | 2012-12-21 | |
| (97) | Date of publication of the European application | 2014-10-29 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/071495 |
| Date | 2012-12-21 |
| (87) | Number | WO 2013/096912 |
| Date | 2013-06-27 |
| (30) | Number | Date | Country code |
| 201161580027 P | 2011-12-23 | US | |
| 201261590797 P | 2012-01-25 | US | |
| 201261590804 P | 2012-01-25 | US | |
| 201261609173 P | 2012-03-09 | US | |
| 201261734365 P | 2012-12-06 | US |
| (72) |
BARBIER, Ann, US
MCCAULEY, Thomas, US
RICHARD, Charles, W., III, US
|
| (73) |
Shire Human Genetic Therapies, Inc.,
300 Shire Way, Lexington MA 02421,
US
|
| (54) | TREATMENT OF COGNITIVE IMPAIRMENT OF HUNTER SYNDROME BY INTRATHECAL DELIVERY OF IDURONATE-2-SULFATASE |
| TREATMENT OF COGNITIVE IMPAIRMENT OF HUNTER SYNDROME BY INTRATHECAL DELIVERY OF IDURONATE-2-SULFATASE |